The prognostic value of the tumor/microenvironment signature compared to early pet scan in advanced-stage, ABVD-treated Hodgkin lymphoma patients

被引：0
作者：
Gallamini, A. [1 ]
Agostinelli, C. [2 ]
Rigacci, L.
D'Amore, F.
Merli, F.
Zinzani, P.
Vitolo, U.
Patti, C.
Stelitano, C.
Di Raimondo, F.
Levis, A.
Trentin, L.
Chisesi, T.
Kamper, P.
Pileri, S. [2 ]
机构：
[1] Azienda Osped S Croce & Carle, Cuneo, Italy
[2] Univ Bologna, Hemopathol Unit, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
[21]   Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma [J].
Kobe, Carsten ;
Goergen, Helen ;
Baues, Christian ;
Kuhnert, Georg ;
Voltin, Conrad-Amadeus ;
Zijlstra, Josee ;
Hoekstra, Otto ;
Mettler, Jasmin ;
Drzezga, Alexander ;
Engert, Andreas ;
Borchmann, Peter ;
Dietlein, Markus .
BLOOD, 2018, 132 (21) :2273-2279
[22]   Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) :758-760
[23]   Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy [J].
Gobbi, Paolo G. ;
Bassi, Emilio ;
Bergonzi, Manuela ;
Merli, Francesco ;
Coriani, Chiara ;
Iannitto, Emilio ;
Luminari, Stefano ;
Polimeno, Giuseppe ;
Federico, Massimo .
HEMATOLOGICAL ONCOLOGY, 2012, 30 (04) :194-199
[24]   The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma [J].
Koca, Oguzhan ;
Ozyurt, Berk ;
Umar, Aysenur ;
Ozmen, Deniz ;
Elverdi, Tugrul ;
Salihoglu, Ayse ;
Ar, Muhlis Cem ;
Baslar, Zafer ;
Eskazan, Ahmet Emre .
ANNALS OF HEMATOLOGY, 2025, 104 (03) :1765-1775
[25]   Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study [J].
Borchmann, Peter ;
Goergen, Helen ;
Kobe, Carsten ;
Lohri, Andreas ;
Greil, Richard ;
Eichenauer, Dennis A. ;
Zijlstra, Josee M. ;
Markova, Jana ;
Meissner, Julia ;
Feuring-Buske, Michaela ;
Huttmann, Andreas ;
Dierlamm, Judith ;
Sokler, Martin ;
Krause, Stefan W. ;
Eich, Hans ;
Baues, Christian ;
Kreissl, Stefanie ;
Fuchs, Michael ;
Dietlein, Markus ;
Engert, Andreas .
BLOOD, 2017, 130
[26]   The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma [J].
Cimino, Giuseppe ;
Zaucha, Jan Maciej ;
Cirillo, S. ;
Saviolo, C. ;
Hutchings, Martin ;
El-Galaly, T. C. ;
Borra, Anna ;
Rago, Angela ;
Gallamini, Andrea .
BLOOD, 2014, 124 (21)
[27]   Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD [J].
Fiore, F. ;
Patti, K. ;
Viviani, S. ;
Rossi, A. ;
Di Raimondo, F. ;
Cantonetti, M. ;
Feldman, T. ;
Biggi, A. ;
Barrington, S. ;
Gallamini, A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[28]   ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma [J].
Hartridge-Lambert, Sidonie K. ;
Schoeder, Heiko ;
Lim, Remy C. ;
Maragulia, Jocelyn C. ;
Portlock, Carol S. .
CANCER, 2013, 119 (06) :1203-1209
[29]   Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) :129-131
[30]   Treatment outcome in patients with advanced-stage Hodgkin's lymphoma after developing drug intolerance to components of ABVD or BEACOPP regimens [J].
Bogatyreva, T. ;
Kravtchenko, T. ;
Strelnikova, E. ;
Nestaiko, T. .
EJC SUPPLEMENTS, 2007, 5 (04) :352-352
12345